These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25670513)

  • 21. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. IV. Application of long polymerase chain reaction for identification of CYP2D6 gene duplication.
    Pułczyńska A; Łukaszkiewicz J; Wojnar M; Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
    Acta Pol Pharm; 2011; 68(1):9-13. PubMed ID: 21485696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
    Caudle KE; Dunnenberger HM; Freimuth RR; Peterson JF; Burlison JD; Whirl-Carrillo M; Scott SA; Rehm HL; Williams MS; Klein TE; Relling MV; Hoffman JM
    Genet Med; 2017 Feb; 19(2):215-223. PubMed ID: 27441996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics in biological perspective.
    Kalow W
    Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetic testing: time for clinical practice guidelines.
    Amstutz U; Carleton BC
    Clin Pharmacol Ther; 2011 Jun; 89(6):924-7. PubMed ID: 21508939
    [No Abstract]   [Full Text] [Related]  

  • 25. Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.
    Zhou Y; Ingelman-Sundberg M; Lauschke VM
    Clin Pharmacol Ther; 2017 Oct; 102(4):688-700. PubMed ID: 28378927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current availability of genetic information of drug metabolizing enzymes, particularly on cytochrome P450(CYP)].
    Yamazoe Y; Nagata K
    Nihon Rinsho; 2001 Aug; 59(8):1614-23. PubMed ID: 11519169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
    Takada K; Arefayene M; Desta Z; Yarboro CH; Boumpas DT; Balow JE; Flockhart DA; Illei GG
    Arthritis Rheum; 2004 Jul; 50(7):2202-10. PubMed ID: 15248218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.
    Ingelman-Sundberg M
    Trends Pharmacol Sci; 2004 Apr; 25(4):193-200. PubMed ID: 15063083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment.
    Brockmöller J; Kirchheiner J; Meisel C; Roots I
    Pharmacogenomics; 2000 May; 1(2):125-51. PubMed ID: 11256586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics).
    Fricke-Galindo I; Jung-Cook H; LLerena A; López-López M
    Drug Metab Pers Ther; 2016 Jun; 31(2):61-81. PubMed ID: 26812836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Where are we today with personalized medicine?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Nov; 50(11):11-3. PubMed ID: 23066831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetics of cytochrome P450 (CYP) in the elderly.
    Seripa D; Pilotto A; Panza F; Matera MG; Pilotto A
    Ageing Res Rev; 2010 Oct; 9(4):457-74. PubMed ID: 20601196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.
    Reis-Pardal J; Rodrigues A; Rodrigues E; Fernandez-Llimos F
    Pharmacogenomics J; 2017 Dec; 17(6):488-493. PubMed ID: 27241061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.
    Kalman LV; Agúndez J; Appell ML; Black JL; Bell GC; Boukouvala S; Bruckner C; Bruford E; Caudle K; Coulthard SA; Daly AK; Del Tredici A; den Dunnen JT; Drozda K; Everts RE; Flockhart D; Freimuth RR; Gaedigk A; Hachad H; Hartshorne T; Ingelman-Sundberg M; Klein TE; Lauschke VM; Maglott DR; McLeod HL; McMillin GA; Meyer UA; Müller DJ; Nickerson DA; Oetting WS; Pacanowski M; Pratt VM; Relling MV; Roberts A; Rubinstein WS; Sangkuhl K; Schwab M; Scott SA; Sim SC; Thirumaran RK; Toji LH; Tyndale RF; van Schaik R; Whirl-Carrillo M; Yeo K; Zanger UM
    Clin Pharmacol Ther; 2016 Feb; 99(2):172-85. PubMed ID: 26479518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recommendations for performing pharmacogenetic tests in drug monographs in Canada, France and the United States].
    Marquot G; Frison C; Lebel D; Bussières JF; Métras MÉ
    Ann Pharm Fr; 2020 Sep; 78(5):447-457. PubMed ID: 32777298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.
    Gaedigk A; Ingelman-Sundberg M; Miller NA; Leeder JS; Whirl-Carrillo M; Klein TE;
    Clin Pharmacol Ther; 2018 Mar; 103(3):399-401. PubMed ID: 29134625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correcting the record on DNA direct.
    Bombard AT; Brown T
    Science; 2008 Aug; 321(5890):769-71; author reply 769-71. PubMed ID: 18687939
    [No Abstract]   [Full Text] [Related]  

  • 39. Enabling the curation of your pharmacogenetic study.
    McDonagh Em; Whirl-Carrillo M; Altman RB; Klein TE
    Clin Pharmacol Ther; 2015 Feb; 97(2):116-9. PubMed ID: 25670512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
    Altar CA; Carhart JM; Allen JD; Hall-Flavin DK; Dechairo BM; Winner JG
    Pharmacogenomics J; 2015 Oct; 15(5):443-51. PubMed ID: 25686762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.